• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于可解释机器学习模型预测中国2型糖尿病患者发生瘦型非酒精性脂肪性肝病的风险

Predicting the risk of lean non-alcoholic fatty liver disease based on interpretable machine models in a Chinese T2DM population.

作者信息

Bao Shixue, Jin Qiankai, Wang Tieqiao, Mao Yushan, Huang Guoqing

机构信息

Department of Endocrinology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.

Department of Endocrinology, Beilun People's Hospital, Ningbo, Zhejiang, China.

出版信息

Front Endocrinol (Lausanne). 2025 Jul 11;16:1626203. doi: 10.3389/fendo.2025.1626203. eCollection 2025.

DOI:10.3389/fendo.2025.1626203
PMID:40717804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12289481/
Abstract

BACKGROUND

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, seriously threatening the public health. Although the proportion of patients with lean NAFLD is lower than that of patients with obese NALFD, it should not be overlooked. This study aimed to construct interpretable machine learning models for predicting lean NAFLD risk in type 2 diabetes mellitus (T2DM) patients.

METHODS

This study enrolled 1,553 T2DM individuals who received health care at the First Affiliated Hospital of Ningbo University, Ningbo, China, from November 2019 to November 2024. Feature screening was performed using the Boruta algorithm and the Least Absolute Shrinkage and Selection Operator (LASSO). Linear discriminant analysis (LDA), logistic regression (LR), Naive Bayes (NB), random forest (RF), support vector machine (SVM), and extreme gradient boosting (XGboost) were used in constructing risk prediction models for lean NAFLD in T2DM patients. The area under the receiver operating characteristic curve (AUC) was used to assess the predictive capacity of the model. Additionally, we employed SHapley Additive exPlanations (SHAP) analysis to unveil the specific contributions of individual features in the machine learning model to the prediction results.

RESULTS

The prevalence of lean NAFLD in the study population was 20.3%. Eight variables, including age, body mass index (BMI), and alanine aminotransferase (ALT), were identified as independent risk factors for lean NAFLD. Ten predictive factors, including BMI, ALT, and aspartate aminotransferase (AST), were screened for the construction of risk prediction models. The random forest model demonstrated superior performance compared to alternative machine learning (ML) algorithms, achieving an AUC of 0.739 (95% confidence interval [CI]: 0.676-0.802) in the training set, and it also exhibited the best predictive value in the internal validation set with an AUC of 0.789 (95% CI: 0.722-0.856). In addition, the SHAP method identified TG, ALT, GGT, BMI, and UA as the top five variables influencing the predictions of the RF model.

CONCLUSION

The construction of lean NAFLD risk models based on the Chinese T2DM population, particularly the RF model, facilitates its early prevention and intervention, thereby reducing the risks of intrahepatic and extrahepatic adverse outcomes.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是最常见的慢性肝病,严重威胁公众健康。尽管非肥胖型NAFLD患者的比例低于肥胖型NALFD患者,但不应被忽视。本研究旨在构建可解释的机器学习模型,用于预测2型糖尿病(T2DM)患者发生非肥胖型NAFLD的风险。

方法

本研究纳入了2019年11月至2024年11月在中国宁波大学附属第一医院接受医疗保健的1553例T2DM患者。使用Boruta算法和最小绝对收缩和选择算子(LASSO)进行特征筛选。采用线性判别分析(LDA)、逻辑回归(LR)、朴素贝叶斯(NB)、随机森林(RF)、支持向量机(SVM)和极端梯度提升(XGboost)构建T2DM患者非肥胖型NAFLD的风险预测模型。采用受试者操作特征曲线下面积(AUC)评估模型的预测能力。此外,我们采用SHapley加法解释(SHAP)分析来揭示机器学习模型中各个特征对预测结果的具体贡献。

结果

研究人群中非肥胖型NAFLD的患病率为20.3%。年龄、体重指数(BMI)和丙氨酸转氨酶(ALT)等8个变量被确定为非肥胖型NAFLD的独立危险因素。筛选出BMI、ALT和天冬氨酸转氨酶(AST)等10个预测因子用于构建风险预测模型。与其他机器学习(ML)算法相比,随机森林模型表现出更好的性能,在训练集中的AUC为0.739(95%置信区间[CI]:0.676-0.802),在内部验证集中也表现出最佳的预测价值,AUC为0.789(95%CI:0.722-0.856)。此外,SHAP方法确定甘油三酯(TG)、ALT、γ-谷氨酰转移酶(GGT)、BMI和尿酸(UA)是影响RF模型预测的前五个变量。

结论

基于中国T2DM人群构建非肥胖型NAFLD风险模型,尤其是RF模型,有助于其早期预防和干预,从而降低肝内和肝外不良结局的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/5c7a0ff18d48/fendo-16-1626203-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/1cc4755d4c64/fendo-16-1626203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/23b40102b5b6/fendo-16-1626203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/4201ce3ba699/fendo-16-1626203-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/2d4baf51e6e2/fendo-16-1626203-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/4bb4f355133c/fendo-16-1626203-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/9114a5a53980/fendo-16-1626203-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/c78e7d6a8f5a/fendo-16-1626203-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/ecd3f87900f9/fendo-16-1626203-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/69645b531bd2/fendo-16-1626203-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/95d325d77076/fendo-16-1626203-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/5c7a0ff18d48/fendo-16-1626203-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/1cc4755d4c64/fendo-16-1626203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/23b40102b5b6/fendo-16-1626203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/4201ce3ba699/fendo-16-1626203-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/2d4baf51e6e2/fendo-16-1626203-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/4bb4f355133c/fendo-16-1626203-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/9114a5a53980/fendo-16-1626203-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/c78e7d6a8f5a/fendo-16-1626203-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/ecd3f87900f9/fendo-16-1626203-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/69645b531bd2/fendo-16-1626203-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/95d325d77076/fendo-16-1626203-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14e5/12289481/5c7a0ff18d48/fendo-16-1626203-g011.jpg

相似文献

1
Predicting the risk of lean non-alcoholic fatty liver disease based on interpretable machine models in a Chinese T2DM population.基于可解释机器学习模型预测中国2型糖尿病患者发生瘦型非酒精性脂肪性肝病的风险
Front Endocrinol (Lausanne). 2025 Jul 11;16:1626203. doi: 10.3389/fendo.2025.1626203. eCollection 2025.
2
Interpretable machine learning analysis of immunoinflammatory biomarkers for predicting CHD among NAFLD patients.用于预测非酒精性脂肪性肝病患者冠心病的免疫炎症生物标志物的可解释机器学习分析
Cardiovasc Diabetol. 2025 Jul 3;24(1):263. doi: 10.1186/s12933-025-02818-1.
3
Supervised Machine Learning Models for Predicting Sepsis-Associated Liver Injury in Patients With Sepsis: Development and Validation Study Based on a Multicenter Cohort Study.用于预测脓毒症患者脓毒症相关肝损伤的监督式机器学习模型:基于多中心队列研究的开发与验证研究
J Med Internet Res. 2025 May 26;27:e66733. doi: 10.2196/66733.
4
Interpretable machine learning for predicting isolated basal septal hypertrophy.用于预测孤立性基底间隔肥厚的可解释机器学习。
PLoS One. 2025 Jun 30;20(6):e0325992. doi: 10.1371/journal.pone.0325992. eCollection 2025.
5
Construction of a novel online calculator for prediction of osteoporosis risk in Chinese type 2 diabetes patients.构建一种新型在线计算器,用于预测中国2型糖尿病患者的骨质疏松风险。
Exp Gerontol. 2025 Sep;208:112819. doi: 10.1016/j.exger.2025.112819. Epub 2025 Jun 24.
6
Machine Learning Model for Predicting Coronary Heart Disease Risk: Development and Validation Using Insights From a Japanese Population-Based Study.预测冠心病风险的机器学习模型:基于日本人群研究的见解进行开发与验证
JMIR Cardio. 2025 May 12;9:e68066. doi: 10.2196/68066.
7
Interpretable XGBoost model identifies idiopathic central precocious puberty in girls using four clinical and imaging features.可解释的XGBoost模型利用四种临床和影像学特征识别女童特发性中枢性性早熟。
BMC Endocr Disord. 2025 Jul 1;25(1):159. doi: 10.1186/s12902-025-01983-4.
8
Diabetic peripheral neuropathy detection of type 2 diabetes using machine learning from TCM features: a cross-sectional study.基于中医特征运用机器学习检测2型糖尿病患者的糖尿病周围神经病变:一项横断面研究
BMC Med Inform Decis Mak. 2025 Feb 18;25(1):90. doi: 10.1186/s12911-025-02932-w.
9
Construction and validation of HBV-ACLF bacterial infection diagnosis model based on machine learning.基于机器学习的HBV-ACLF细菌感染诊断模型的构建与验证
BMC Infect Dis. 2025 Jul 1;25(1):847. doi: 10.1186/s12879-025-11199-5.
10
Optimized feature selection and advanced machine learning for stroke risk prediction in revascularized coronary artery disease patients.优化特征选择与先进机器学习用于预测冠状动脉疾病血运重建患者的卒中风险
BMC Med Inform Decis Mak. 2025 Jul 24;25(1):276. doi: 10.1186/s12911-025-03116-2.

本文引用的文献

1
The spleen-liver axis supports obesity-induced systemic and fatty liver inflammation via MDSC and NKT cell enrichment.脾-肝轴通过富集髓源性抑制细胞(MDSC)和自然杀伤T细胞(NKT细胞),促进肥胖诱导的全身炎症和脂肪肝炎症。
Mol Cell Endocrinol. 2025 May 1;601:112518. doi: 10.1016/j.mce.2025.112518. Epub 2025 Mar 5.
2
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2025.4. 合并症的综合医学评估与评定:2025年糖尿病照护标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S59-S85. doi: 10.2337/dc25-S004.
3
Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations.
瘦人群与非瘦人群中代谢功能障碍相关脂肪性肝病的长期结局及风险修饰因素
Clin Mol Hepatol. 2025 Jan;31(1):74-89. doi: 10.3350/cmh.2024.0631. Epub 2024 Oct 23.
4
Liver and cardiovascular outcomes in lean non-alcoholic fatty liver disease: an updated systematic review and meta-analysis of about 1 million individuals.瘦型非酒精性脂肪性肝病患者的肝脏和心血管结局:约 100 万人的更新系统评价和荟萃分析。
Hepatol Int. 2024 Oct;18(5):1396-1415. doi: 10.1007/s12072-024-10716-z. Epub 2024 Aug 8.
5
Surveillance of the liver in type 2 diabetes: important but unfeasible?2 型糖尿病的肝脏监测:重要但不可行?
Diabetologia. 2024 Jun;67(6):961-973. doi: 10.1007/s00125-024-06087-7. Epub 2024 Feb 9.
6
Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis.非酒精性脂肪肝和全因死亡率的关系:一项更新的荟萃分析。
Ann Hepatol. 2024 May-Jun;29(3):101288. doi: 10.1016/j.aohep.2024.101288. Epub 2024 Jan 24.
7
Machine learning identifies ferroptosis-related gene ANXA2 as potential diagnostic biomarkers for NAFLD.机器学习确定与铁死亡相关的基因 ANXA2 为 NAFLD 的潜在诊断生物标志物。
Front Endocrinol (Lausanne). 2023 Dec 19;14:1303426. doi: 10.3389/fendo.2023.1303426. eCollection 2023.
8
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis.全球 2 型糖尿病中非酒精性脂肪性肝病的患病率:一项更新的系统评价和荟萃分析。
Gut. 2023 Nov;72(11):2138-2148. doi: 10.1136/gutjnl-2023-330110. Epub 2023 Jul 25.
9
Addendum. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S19-S40.附录2. 糖尿病的分类与诊断:《2023年糖尿病医疗护理标准》。《糖尿病护理》2023年;46(增刊1):S19 - S40。
Diabetes Care. 2023 Sep 1;46(9):1715. doi: 10.2337/dc23-ad08.
10
Type 2 Diabetes Mellitus and Liver Disease: Across the Gut-Liver Axis from Fibrosis to Cancer.2 型糖尿病与肝脏疾病:从肝纤维化到肝癌的肝肠轴途径。
Nutrients. 2023 May 29;15(11):2521. doi: 10.3390/nu15112521.